S&P 500   3,977.53
DOW   32,432.08
QQQ   308.76
Should You Buy Before the Ex-Dividend Date or Wait?
Biden To Unleash "Choke Point" Operation On America? (Ad)
Dividends, Short-Term Pain, but Long-Term Gain?
Can Carnival Cruise Lines Set Sail For New Highs? 
Biden To Unleash "Choke Point" Operation On America? (Ad)
BioNTech Is Ripe For A Rebound In 2023 
If Safety is Your Concern, Then Take a Look at Sandy Spring Bank
Buy THIS stock before Taiwan is attacked (Ad)
Sanofi, Regeneron Shares Pop On Big News About COPD Treatment
Is Block a Ticking Time Bomb or a Bargain Bestowed by Hindenburg?
S&P 500   3,977.53
DOW   32,432.08
QQQ   308.76
Should You Buy Before the Ex-Dividend Date or Wait?
Biden To Unleash "Choke Point" Operation On America? (Ad)
Dividends, Short-Term Pain, but Long-Term Gain?
Can Carnival Cruise Lines Set Sail For New Highs? 
Biden To Unleash "Choke Point" Operation On America? (Ad)
BioNTech Is Ripe For A Rebound In 2023 
If Safety is Your Concern, Then Take a Look at Sandy Spring Bank
Buy THIS stock before Taiwan is attacked (Ad)
Sanofi, Regeneron Shares Pop On Big News About COPD Treatment
Is Block a Ticking Time Bomb or a Bargain Bestowed by Hindenburg?
S&P 500   3,977.53
DOW   32,432.08
QQQ   308.76
Should You Buy Before the Ex-Dividend Date or Wait?
Biden To Unleash "Choke Point" Operation On America? (Ad)
Dividends, Short-Term Pain, but Long-Term Gain?
Can Carnival Cruise Lines Set Sail For New Highs? 
Biden To Unleash "Choke Point" Operation On America? (Ad)
BioNTech Is Ripe For A Rebound In 2023 
If Safety is Your Concern, Then Take a Look at Sandy Spring Bank
Buy THIS stock before Taiwan is attacked (Ad)
Sanofi, Regeneron Shares Pop On Big News About COPD Treatment
Is Block a Ticking Time Bomb or a Bargain Bestowed by Hindenburg?
S&P 500   3,977.53
DOW   32,432.08
QQQ   308.76
Should You Buy Before the Ex-Dividend Date or Wait?
Biden To Unleash "Choke Point" Operation On America? (Ad)
Dividends, Short-Term Pain, but Long-Term Gain?
Can Carnival Cruise Lines Set Sail For New Highs? 
Biden To Unleash "Choke Point" Operation On America? (Ad)
BioNTech Is Ripe For A Rebound In 2023 
If Safety is Your Concern, Then Take a Look at Sandy Spring Bank
Buy THIS stock before Taiwan is attacked (Ad)
Sanofi, Regeneron Shares Pop On Big News About COPD Treatment
Is Block a Ticking Time Bomb or a Bargain Bestowed by Hindenburg?
NASDAQ:AMEH

Apollo Medical - AMEH Stock Forecast, Price & News

$39.05
+0.86 (+2.25%)
(As of 03/27/2023 12:00 AM ET)
Add
Compare
Today's Range
$38.35
$39.64
50-Day Range
$32.65
$39.66
52-Week Range
$26.89
$58.00
Volume
153,075 shs
Average Volume
181,201 shs
Market Capitalization
$2.24 billion
P/E Ratio
36.84
Dividend Yield
N/A
Price Target
$58.50

Apollo Medical MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.67 Rating Score
Upside/​Downside
49.8% Upside
$58.50 Price Target
Short Interest
Bearish
8.13% of Float Sold Short
Dividend Strength
N/A
Sustainability
-0.69
Upright™ Environmental Score
News Sentiment
1.35mentions of Apollo Medical in the last 14 days
Based on 3 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
21.00%
From $1.00 to $1.21 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.64 out of 5 stars

Medical Sector

196th out of 995 stocks

Management Consulting Services Industry

10th out of 17 stocks


AMEH stock logo

About Apollo Medical (NASDAQ:AMEH) Stock

Apollo Medical Holdings, Inc. is a physician-centric, technology-powered, risk-bearing healthcare management company, which engages in the provision of care coordination services and a healthcare delivery platform. The company was founded on November 1, 1985 and is headquartered in Alhambra, CA.

Receive AMEH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Apollo Medical and its competitors with MarketBeat's FREE daily newsletter.

AMEH Stock News Headlines

Fed's Shocking New Plan to Control Your Money
The Federal Reserve has a disturbing plan that is getting ready to roll out as soon as May. This is a lot more than printing trillions of dollars or manipulating interest rates. It's about every checking account, every purchase and every money transfer in America — including yours and mine. 
Fed's Shocking New Plan to Control Your Money
The Federal Reserve has a disturbing plan that is getting ready to roll out as soon as May. This is a lot more than printing trillions of dollars or manipulating interest rates. It's about every checking account, every purchase and every money transfer in America — including yours and mine. 
See More Headlines
Receive AMEH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Apollo Medical and its competitors with MarketBeat's FREE daily newsletter.

AMEH Company Calendar

Last Earnings
11/04/2021
Today
3/27/2023
Next Earnings (Estimated)
5/04/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Management consulting services
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:AMEH
Employees
1,362
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$58.50
High Stock Price Forecast
$60.00
Low Stock Price Forecast
$57.00
Forecasted Upside/Downside
+49.8%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.67
Research Coverage
3 Analysts

Profitability

Net Income
$49.05 million
Pretax Margin
7.57%

Debt

Sales & Book Value

Annual Sales
$1.14 billion
Cash Flow
$1.28 per share
Book Value
$9.78 per share

Miscellaneous

Free Float
50,824,000
Market Cap
$2.24 billion
Optionable
Not Optionable
Beta
0.77

Social Links


Key Executives

  • Thomas S. Lam
    President, Co-Chief Executive Officer & Director
  • Brandon SimBrandon Sim
    Co-Chief Executive Officer
  • Rita Pew
    Vice President-Strategy & Operations
  • Chan Basho
    Chief Financial & Strategy Officer
  • Albert Young
    Chief Administration Officer













AMEH Stock - Frequently Asked Questions

Should I buy or sell Apollo Medical stock right now?

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Apollo Medical in the last year. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" AMEH shares.
View AMEH analyst ratings
or view top-rated stocks.

What is Apollo Medical's stock price forecast for 2023?

3 equities research analysts have issued twelve-month target prices for Apollo Medical's shares. Their AMEH share price forecasts range from $57.00 to $60.00. On average, they anticipate the company's share price to reach $58.50 in the next twelve months. This suggests a possible upside of 49.8% from the stock's current price.
View analysts price targets for AMEH
or view top-rated stocks among Wall Street analysts.

How have AMEH shares performed in 2023?

Apollo Medical's stock was trading at $29.59 on January 1st, 2023. Since then, AMEH shares have increased by 32.0% and is now trading at $39.05.
View the best growth stocks for 2023 here
.

Are investors shorting Apollo Medical?

Apollo Medical saw a decline in short interest in the month of March. As of March 15th, there was short interest totaling 3,500,000 shares, a decline of 5.1% from the February 28th total of 3,690,000 shares. Based on an average daily trading volume, of 179,400 shares, the days-to-cover ratio is currently 19.5 days. Approximately 8.1% of the shares of the stock are short sold.
View Apollo Medical's Short Interest
.

When is Apollo Medical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 4th 2023.
View our AMEH earnings forecast
.

How were Apollo Medical's earnings last quarter?

Apollo Medical Holdings, Inc. (NASDAQ:AMEH) issued its earnings results on Thursday, November, 4th. The company reported $0.69 EPS for the quarter, beating analysts' consensus estimates of $0.34 by $0.35. The firm earned $227.12 million during the quarter. Apollo Medical had a net margin of 4.29% and a trailing twelve-month return on equity of 10.37%. During the same quarter in the previous year, the business earned $0.45 earnings per share.

What guidance has Apollo Medical issued on next quarter's earnings?

Apollo Medical updated its FY 2023 earnings guidance on Thursday, February, 23rd. The company provided EPS guidance of $0.95-$1.20 for the period, compared to the consensus EPS estimate of $0.97. The company issued revenue guidance of $1.30 billion-$1.50 billion, compared to the consensus revenue estimate of $1.23 billion.

What is Thomas Lam's approval rating as Apollo Medical's CEO?

15 employees have rated Apollo Medical Chief Executive Officer Thomas Lam on Glassdoor.com. Thomas Lam has an approval rating of 43% among the company's employees. This puts Thomas Lam in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies. 28.0% of employees surveyed would recommend working at Apollo Medical to a friend.

What other stocks do shareholders of Apollo Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Apollo Medical investors own include PayPal (PYPL), SEA (SE), Mastercard (MA), NVIDIA (NVDA), Walt Disney (DIS), Lululemon Athletica (LULU), Enphase Energy (ENPH), Main Street Capital (MAIN), Block (SQ) and Exxon Mobil (XOM).

What is Apollo Medical's stock symbol?

Apollo Medical trades on the NASDAQ under the ticker symbol "AMEH."

Who are Apollo Medical's major shareholders?

Apollo Medical's stock is owned by many different retail and institutional investors. Top institutional investors include Geode Capital Management LLC (1.34%), Dimensional Fund Advisors LP (0.72%), Charles Schwab Investment Management Inc. (0.53%), Principal Financial Group Inc. (0.44%), Morgan Stanley (0.43%) and Legal & General Group Plc (0.17%). Insiders that own company stock include Adrian Vazquez, Albert Waichow Young, Brandon Sim, Eric Chin, Linda Marsh, Physicians Of Californi Allied and Thomas S Lam.
View institutional ownership trends
.

How do I buy shares of Apollo Medical?

Shares of AMEH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Apollo Medical's stock price today?

One share of AMEH stock can currently be purchased for approximately $39.05.

How much money does Apollo Medical make?

Apollo Medical (NASDAQ:AMEH) has a market capitalization of $2.24 billion and generates $1.14 billion in revenue each year. The company earns $49.05 million in net income (profit) each year or $1.06 on an earnings per share basis.

How many employees does Apollo Medical have?

The company employs 1,362 workers across the globe.

Does Apollo Medical have any subsidiaries?
The following companies are subsidiares of Apollo Medical: Standard Aero (alliance) Inc..
Read More
How can I contact Apollo Medical?

Apollo Medical's mailing address is 1668 S. GARFIELD AVENUE 2ND FLOOR, ALHAMBRA CA, 91801. The official website for the company is www.apollomed.net. The company can be reached via phone at (626) 282-0288, via email at investors@apollomed.net, or via fax at 818-839-5190.

This page (NASDAQ:AMEH) was last updated on 3/28/2023 by MarketBeat.com Staff